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Abstract
Objective—Vitamin D and the vitamin D receptor (VDR) appear to be important immunological 
regulators of inflammatory bowel diseases (IBD). Defective autophagy has also been implicated in 
IBD, where interestingly, polymorphisms of genes such as ATG16L1 have been associated with 
increased risk. Although vitamin D, the microbiome, and autophagy are all involved in 
pathogenesis of IBD, it remains unclear whether these processes are related or function 
independently.
Design—We investigated the effects and mechanisms of intestinal epithelial VDR in healthy and 
inflamed states using cell culture models, a conditional VDR knockout mouse model (VDRΔIEC), 
colitis models, and human samples.
Results—Absence of intestinal epithelial VDR affects microbial assemblage and increases 
susceptibility to dextran sulfate sodium-induced colitis. Intestinal epithelial VDR down-regulates 
expressions of ATG16L1 and lysozyme, and impairs anti-microbial function of Paneth cells. Gain 
and loss of function assays showed that VDR levels regulate ATG16L1 and lysozyme at the 
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transcriptional and translational levels. Moreover, low levels of intestinal epithelial VDR 
correlated with reduced ATG16L1 and representation by intestinal Bacteroides in IBD patients. 
Administration of the butyrate (a fermentation product of gut microbes) increases intestinal VDR 
expression and suppresses inflammation in a colitis model.
Conclusions—Our study demonstrates fundamental relationship between VDR, autophagy, and 
gut microbial assemblage that is essential for maintaining intestinal homeostasis, but also in 
contributing to the pathophysiology of IBD. These insights can be leveraged to define therapeutic 
targets for restoring VDR expression and function.
Keywords
ATG16L1; Autophagy; bacteria; intestine; inflammation; nuclear receptor; transcriptional factor; 
vitamin D; Vitamin D receptor; Vitamin D response element (VDRE)
Introduction
Vitamin D deficiency is a critical factor in the pathology of IBD, colon cancer, autoimmune 
diseases, and other diseases.1-7 Low vitamin D status has been observed in IBD patients.8-10 
Anorth-south gradient in rates of Crohn’s disease (CD) suggests that vitamin D deficiency 
may be an environmental trigger contributing to the pathogenesis of IBD.9 Vitamin D also 
influences the course and severity of IBD.9 The vitamin D receptor (VDR), a nuclear 
receptor,11 mediates most known functions of 1,25-dihydroxyvitamin D (Vitamin D3), the 
active form of vitamin D. VDR and vitamin D3 are recognized as key players in calcium 
homeostasis and in electrolyte and blood pressure regulation.12 More recent evidence 
demonstrates that vitamin D3, is an immunoregulatory hormone that modulates the innate 
and adaptive immune system.13-15 Vitamin D/VDR appears to be important immunological 
regulators of IBD.16, 17 Moreover, polymorphisms in the VDR gene are associated with 
increased susceptibility to IBD.18-22 VDR expression is significantly decreased in IBD 
patients.8, 23 Although it is possible that decreased VDR is a consequence of chronic 
inflammation in IBD, in experimental murine models of colitis, VDR knockout (KO) mice 
spontaneously develop colitis.24 Whole body VDR/IL-10 double KO mice develop a more 
severe colitis involving the entire intestinal tract.24 Mice lacking VDR activate the 
proinflammatory NF-κB pathway and are susceptible to Salmonella-colitis and chemical-
induced colitis.25, 26 These findings suggest a critical role of VDR in maintaining intestinal 
homeostasis and possibly in causing/contributing to human IBD.
VDR also functions as a transcription factor.27 Target genes of VDR include anti-microbial 
peptide (AMPs) cathelicidin antimicrobial peptide 28, 29 (also called LL-37), β-defensin,29 
and the 1, 25(OH) 2D3-regulated VDR-specific, Cyp24 hydroxylase gene. Indeed, ~3% of 
the mouse and human genomes are regulated directly or indirectly by the vitamin D 
endocrine system, further supporting the possibility of widespread effects of vitamin D and 
VDR in disease mechanisms.30-32 For example, epidemiological and experimental studies 
have indicated a protective action of vitamin D against colorectal cancer and upper GI 
cancers.33-40 Upregulation of VDR leads to induction of AMPs and the killing of 
intracellular Mycobacterium tuberculosis in human macrophages.41 Paneth cells are 
specialized intestinal epithelial cells located at the bottom of ileal crypts. The granules of 
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Paneth cells contain AMPs—α-defensins, lysozyme, and secretory phospholipase A2.42-44 
Paneth cells are a major source of monocyte chemotactic protein 1(MCP-1)45 and also 
produce the cytokine IL-17.46 A recent study demonstrated Paneth cells as a site of origin 
for intestinal inflammation.47 Thus, Paneth cells play a key role in innate immune responses 
and in shaping the gut microbiota.48 However, VDR regulation of Paneth cell function is not 
known.
Autophagy is a highly conserved process that is involved in intracellular homeostasis 
through the degradation and recycling of cytosolic contents and organelles, as well as in 
promoting the removal of intracellular microbes and immunity against infection.49, 50 
Interestingly, three IBD susceptibility genes, IRGM, Nod2, and ATG16L1, are involved in 
autophagy.51-53 Deficits in the autophagy pathway can impair Paneth cell function in CD 
patients.54, 55 Autophagy can affect the biosynthesis or quality control of the lysosomal 
pathway in Paneth cell granules. Paneth cells with fewer granules might be a result of 
Paneth cell exhaustion, compensating for changes elsewhere in the epithelium.54 Expression 
in CD-like mutant Nod2 mouse alleles affect Paneth cells by reducing Nod2-dependent 
production of α-defensins in Paneth cells.56 Nod2 and ATG16L1 are in a common bacterial-
sensing pathway that promotes bacterial antigen presentation. Nod2 recruits ATG16L1 to 
the plasma membrane at the bacterial entry site.57 Moreover, ATG16L1 may have unique 
protective functions, including AMP release in Paneth cells and the negative regulation of 
pro-inflammatory cytokine production.58, 59 Although vitamin D and autophagy are all 
involved in pathogenesis of IBD,60 it remains unclear whether these processes are related or 
function independently. Several studies61, 62 have identified vitamin D as a potent stimulator 
of autophagy in Mycobacterium tuberculosis infection and HIV infection. However, the 
crosstalk among VDR, autophagy, and bacteria in the gut remains unknown.
We have been investigating VDR63, 64 and bacterial inflammation.25, 63-66 We found that, 
on one hand, VDRs negatively regulate bacteria-induced NF-κB activity in intestinal 
inflammation.63 Lack of VDR leads to a reduction of IκBα, an endogenous inhibitor of NF-
κB activity. On the other hand, bacteria regulate intestinal VDR expression in both 
gnotobiotic and bacterial-colitis models.63 Recent studies have also shown alternate 
bacterial profiles in VDR KO mice. VDR may regulate the gut microbes and probably 
contribute to maintenance of physiological host-microbe relationships. This could occur 
through several unique mechanisms that include NF-κB and autophagy. In the current study, 
we hypothesize that the intestinal epithelial VDR is a determinant of IBD risk through its 
actions on the autophagy gene (ATG16L1), thus determining states of Paneth cells and 
microbial assembly in intestinal homeostasis. We investigated mechanisms of intestinal 
epithelial VDR in healthy and inflamed states using a conditional knockout mouse model. 
We show that mice lacking VDR have increased bacterial loads in intestinal mucosa. The 
number of Paneth cells is decreased in the ileum of VDR−/− mice compared to control mice. 
We report that VDR levels correlated with levels of autophagy markers in vitro and in vivo. 
We further show that administration of the bacterial product butyrate increases intestinal 
VDR expression and suppresses inflammation in an experimental colitis model. Hence, our 
study fills an existing gap by characterizing the precise role of intestinal VDR in regulating 
intestinal homeostasis through changing the function of intestinal autophagy.
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Materials and Methods
Human tissue samples
This study was performed in accordance with approval from the University of Rochester 
Ethics Committee (RSRB00037178). Colorectal tissue samples were obtained with informed 
consent from the sigmoid colon of 52 patients (51–83years old) exhibiting no apparent 
intestinal pathology and from the normal mucosa (i.e., >10cm colitis margin) of 30 patients 
undergoing anterior resection (44–85years old).
Animals
VDRloxP/loxP mice were originally developed by Dr. Geert Carmeliet.67 VDRΔIEC mice were 
obtained by crossing the VDRloxP/loxP mice with villin-cre mice (Jackson Laboratory, 
004586). Experiments were performed on 2–3 months old mice. Mice were provided with 
water ad libitum, and maintained in a 12 h dark/light cycle. IL10−/− mice were purchase 
from Jackson Laboratory (002251). All work with animals were approved by the Rush 
University Animal Resources committee.
Induction of colitis
Mice were administered 5% DSS (MW = 40-50 kDa; USB Corp. Cleveland, OH) dissolved 
in filter-purified and sterilized water ad libitum for the experimental period. Animals were 
weighed daily. At day 7 after DSS administration, mice were sacrificed under anaesthesia. 
Severity of colitis was quantified by a disease activity index, determined by weight loss, 
fecal blood, and diarrhea.68
Butyrate treated mice model
Eight IL10−/− mice were divided into control and butyrate group. Butyrate group mice were 
given 2% sodium butyrate (Sigma, St. Louis, MO) water ad libitum for 3 weeks. The 
untreated control group was maintained on tap water throughout the experiment.
Co-housing experiment
Two to three month old female VDRloxP/loxP and VDRΔIEC were co-housed in new cages 
according to previously published methods.69 One cage contained 3 VDRloxP/loxP and 2 
VDRΔIEC, another one contained 2 mice each. The mice were fed with the same food and 
water. After 4 weeks of co-housing, 5% DSS dissolved in filter-purified water was 
administered to the mice. Animals were weighed daily. At day 7 after DSS administration, 
mice were sacrificed under anesthesia.
Cell culture
Mouse embryonic fibroblasts (MEFs), human embryonic intestine INT 407 , HCT116 cells, 
and human colorectal adenocarcinoma SKCO-15 cells were grown in high glucose 
Dulbecco’s Modified Eagle Medium(DMEM) (Hyclone, SH30243.01) containing 10% (v/v) 
fetal bovine serum (GEMINI, 900-108), 50 μg/ml streptomycin, and 50 U/ml 
penicillin(Mediatech, Inc., 30-002CI). INT 407 cells were grown with 1% Non Essential 
Amino Acids (Mediatech, Inc., 25-025CI).
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VDR knockdown of SKCO 15 with shRNA using cells retroviral GFP vector
SKCO-15 cells were transfected (Lipofectamine 2000, Invitrogen Corp.) with VDR shRNA 
retroviral GFP vector (OriGene, TG320568) plasmids targeting human VDR or control, 
scrambled shRNA on the same vector background (Origene) according to the 
manufacturer’s instructions. Briefly, SKCO-15 cells were seeded on day 1 in a six-well plate 
with complete medium and incubated overnight. Medium was replaced on day 2 with fresh 
complete medium containing 5 μg/ml puromycin dihydrochloride (GIBCO A11138-02) for 
6 days. The transduced cells were sorted by GFP detection using flow cytometry and 
cultured in complete medium containing 10 μg/ml puromycin dihydrochloride for 13 
passages.
Vitamin D-Responsive Element Transcriptional Activity
Cells were grown in triplicate and transfected with Cignal Vitamin D Reporter (luc) Kit 
(SABiosciences, Frederick, MD) using Surefect reagent (SABiosciences, Frederick, MD). 
The plasmid for the VDR reporter was a mixture of an inducible Vitamin D-responsive 
firefly luciferase construct and a constitutively expressing Renilla luciferase construct 
(40:1). The negative control was a mixture of a noninducible firefly luciferase construct and 
a constitutively expressing Renilla luciferase construct (40:1). After transfection for 24 
hours, some cells were treated with 10 mM butyrate for 30 hours. Luciferase activity was 
determined using the Dual Luciferase Reporter Assay System (Promega) with a TD- 20/20 
luminometer (Turner Designs, Sunnyvale, CA).
Western blot analysis and antibodies
Mouse ileal epithelial cells were collected by scraping from mouse ileum as previously 
described.65 Briefly, mouse epithelial cells were lysed in lysis buffer (1% Triton X-100 
(Sigma-Aldrich, X100), 150 mM NaCl ( J.T.Baker 3624-19), 10 mM Tris ( Fisher Scientific, 
BP152-5) pH 7.4, 1 mM EDTA(Fisher Scientific, BP120-1), 1 mM EGTA(Sigma-Aldrich, 
E3889) pH 8.0, 0.2 mM sodium ortho-vanadate (Sigma-Aldrich, S6508), and protease 
inhibitor cocktail (Roche Diagnostics, 118367001)). Cultured cells were rinsed twice in ice-
cold HBSS (Sigma-Aldrich, H1387), lysed in protein loading buffer (50 mM Tris, pH 6.8, 
100 mM dithiothreitol (Amresco, 0281), 2% SDS (Sigma-Aldrich, L3771), 0.1% 
bromophenol blue (IBI Scientific, IB74040), and 10% glycerol (Sigma-Aldrich, G5516)), 
and sonicated (Branson Sonifier, 250). Equal amount of protein was separated by SDS-
polyacrylamide gel electrophoresis, transferred to nitrocellulose (Bio-rad, 162-0112), and 
immunoblotted with primary antibodies: VDR (Santa Cruz, sc13133), Beclin-1(Santa Cruz, 
sc10086), Villin (Santa Cruz, sc7672), LC3B (Cell Signal Technology Inc., 2775), 
ATG16L1 (Abgent, AP18176), p62 (Abgent, AP2183B) or β-actin (Sigma-Aldrich,A1978) 
antibodies and visualized by ECL chemiluminescence (Thermo Scientific, 32106).
Histology of Intestine
Intestines were harvested, fixed in 10% formalin (pH 7.4), processed, and paraffin 
embedded. Sections (5μm) were stained with H&E. For immunostaining, antigens were 
retrieved by 10-minute boiling in 10 mM citrate (pH 6.0). The slides were stained with 
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antibodies as previously described.65 Blinded histological inflammatory scores were 
performed by a validated scoring system by a trained pathologist.70
Immunofluorescence
Ileal tissues from the distal portion of the ileum were freshly isolated and paraffin-embedded 
after fixation with 10% neutral buffered formalin. Immunofluorescence was performed on 
paraffin-embedded sections (5 μm). After preparation of the slides as described 
previously,71 tissue samples were incubated with anti-lysozyme (Santa Cruz, sc27958) at 
4°C overnight. Samples were then incubated with sheep anti-goat Alexa Fluor 594 (Life 
technologies, A11058) and DAPI (Life technologies, D1306) for 1 hour at room 
temperature. Tissues were mounted with SlowFade (Life technologies, s2828), followed by 
a coverslip, and the edges were sealed to prevent drying. Specimens were examined with 
Zeiss laser scanning microscope (LSM) 710.
Fluorescence in situ hybridization
Fluorescent in situ hybridization (FISH) was performed using antisense ssDNA probes 
targeting the bacterial 16S rRNA. Bfra602 probe (5'- GAGCCGCAAACTTTCACAA -3') 
for Bacteroides fragilis group.72 Prior to performing the FISH assay, 5 μm tissue sections 
were baked over night at 55°C. Tissue sections were deparaffinized in xylene, dehydrated 
with 100% ethanol, air dried, incubated in 0.2M HCl for 20min and heated in 1 mM sodium 
thiocyanate at 80°C for 10 minutes. Samples were pepsin digested (4% pepsin in 0.01N 
HCl) for 20 minutes at 37°C, washed on slides in wash buffer (0.3 M NaCl, 0.03 M sodium 
citrate, pH 7, and 0. 1% SDS) and fixed on slides in 10% buffered formalin for 15 min, and 
hybridized with the probes at 5 ng/μl concentration each for 5 min at 96°C in hybridization 
buffer (0.9 M NaCl, 30% formamide, 20mMTris-HCl (pH 7.4), and 0.01% sodium dodecyl 
sulfate (SDS) and incubated at 37°C overnight. Slides were washed 4 times for 5 minutes 
each at 45°C in wash buffer. For visualization of the epithelial cell nuclei, the slides were 
counterstained with 4′,6′-diamidino-2-phenylindole (DAPI)/ antifade solution. The slides 
were examined with Zeiss laser scanning microscope (LSM) 710.
Lysotracker staining
Lysotracker-red is a basic cell-permeable probe that accumulates in acidic vesicles. It is 
widely used to reflect lysosomal activity in live cells.61, 73, 74 Lysotracker staining was 
performed following the manufacturer protocol (Lonza Walkersville, Inc.). MEF and INT 
407 cells were grown in the Lab-Tek Chambered Cover glass System (Thermo Scientific,
154526), and the cells were then incubated with 100 nM LysoTracker Red lysosomal 
Probe(Lonza Walkersville,Inc., PA3015) in cell growth medium at 37°Cfor 60 min. After 
washing with HBBS, the cells were detected by fluorescence microscopy (AMG, EVOS fl).
Paneth cells counting
Paneth cells in mouse ileal cells were counted after anti-lysozyme immunofluorescence 
staining. The patterns of lysozyme expression in Paneth cells were classified into four 
categories: normal (D0), disordered (D1), depleted (D2) and diffuse (D3) according to 
published methods.59
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Real Time quantitative PCR
Total RNA was extracted from mouse ileal epithelial cells or cultured cells using TRIzol 
reagent (Life technologies, 15596-02). RNA was first reverse-transcribed into cDNA with 
the iScript cDNA synthesis kit (Bio-Rad, 170-8891) according to the manufacturer’s 
manual. The RT-cDNA reaction products were subjected to quantitative real-time PCR 
using CTFX 96 Real-time system (Bio-Rad,C1000) and SYBR green supermix (Bio-Rad,
172-5124) according to the manufacturer’s directions. All expression levels were normalized 
to β-actin levels of the same sample. Percent expression was calculated as the ratio of the 
normalized value of each sample to that of the corresponding untreated control cells. All 
real-time PCR reactions were performed in triplicate. Optimal primer sequences were 
designed using Primer-BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) or were obtained 
from Primer Bank (http://pga.mgh.harvard.edu/primerbank/) primer pairs listed Table 1
Real-time PCR measurement of bacterial DNA
DNA was extracted from colonic tissues.75 16S rDNA PCR reactions were performed with 
the following primers: Universal bacteria 76 ( forward: 5’- TCCTACGGGAGGCAGCAGT 
-3’; reward:5’- GGACTACCAGGGTATCTAATCCTGTT -3’), E. Coli ( forward: 5’- 
CCTACGGGAGGCAGCAGT -3’; reward:5’-CGTTTACGGCGTGGACTAC -3’), 
Bacteroides fragilis (forward: 5’-GGCGCACGGGTG- AGTAACA-3’; reward:5’-
CAATATTCCTCACTGCTGC-3’) and Butyrivibrio fibrisolvens (forward: 5’-
CTAACACATGCAAGTCGAACG -3’; reward:5’-CCGTGTCTCAGTCCCAATG-3’), 
Primers specific to 18S rRNA77( forward: 5’-AGGGGAGAGCGGGTAAGAGA-3’; 
reward:5’-ggacaggactaggcg- gaaca-3’)were used as an endogenous control to normalize 
loading between samples. The relative amount of 16S rDNA in each sample was estimated 
using the ΔΔCT.
Mucosa microbial and fecal 454 Pyrosequencing
The tubes for microbial sampling were autoclaved and then irradiated with ultraviolet light 
to destroy the environmental bacterial DNA. The mice were then anesthetized and dissected. 
Fecal isolated freshly from the gut and placed into the specially prepared tubes, as described 
in our previously published papers.78, 79 The samples were kept at low temperature with dry 
ice and mailed to Research and Testing Laboratory, Lubbock, TX, for 454 pyrosequencing. 
The V4-V6 region of the samples was amplified in Research and Testing Laboratory, 
Lubbock, TX, for pyrosequencing using a forward and reverse fusion primer. The sequences 
were denoised, subjected to quality checking. Taxonomic identifications were assigned by 
queries against NCBI. Differences in microbial communities between VDRloxP/loxP and 
VDRΔIEC groups were analyzed, as we did in previous studies.78, 79Briefly, Principal 
Coordinates Analysis (PCoA) of unweighted UniFrac distances plots were plotted using 
quantitative insights into microbial ecology (QIIME).80 To determine differences in 
microbiota composition between the animal groups, the analysis of similarities (ANOSIM) 
function in the statistical software package PRIMER 6 (PRIMER-E Ltd., Lutton, UK) was 
used on the unweighted UniFrac distance matrixes.
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Chromatin immunoprecipitation (CHIP) assay
Binding of VDR to the ATG16L1 promoter was investigated using the ChIP assay as 
described previously.25 Briefly, MEF cells were treated with 1% formaldehyde for 10 min at 
37°C. Cells were washed twice in ice-cold phosphate buffered saline containing protease 
inhibitor cocktail tablets (Roche). Cells were scraped into conical tubes, pelleted and lysed 
in SDS Lysis Buffer. The lysate was sonicated to shear DNA into fragments of 200–1000 bp 
(4 cycles of 10 s sonication, 10 s pausing, Branson Sonifier 250, USA). The chromatin 
samples were pre-cleared with salmon sperm DNA–bovine serum albumin-sepharose beads, 
then incubated overnight at 4 °C with VDR antibody (Santa Cruz Biotechnology). Immune 
complexes were precipitated with salmon sperm DNA–bovine serum albumin-sepharose 
beads. DNA was prepared by treatment with proteinase K, extraction with phenol and 
chloroform, and ethanol precipitation. Searching mouse ATG16L1 gene, we found a similar 
sequence as the VDRE sequence “(G/A)G(G/T)TCA”. We then designed primers for ChIP. 
PCR was performed using the following promoter specific primers: ATG16L1 forward, 5’-
GGTTCCGTTCTTGTTTCT- 3’; reverse, 5’-TCAAGTTGT- CTCCAAGATTAT- 3’.
Statistical Analysis—Data are expressed as mean± SD. Differences between two 
samples were analyzed by Student’s t test. Differences among three or more groups were 
analyzed using ANOVA with GraphPad Prism 5. P-values of 0.05 or less were considered 
statistically significant.
Results
Established intestinal VDRΔIEC model
We have established a VDRΔIEC model using the VDRloxP/loxP mouse strain.67, 81 As shown 
in figure 1A and 1B, there was no detectable VDR expression in intestinal epithelial cells of 
VDRΔIEC mice by immunohistochemistry or by Western blot analysis. These data confirm 
that the intestinal VDR knock out is established. The VDRΔIEC model allows us to: 1) focus 
on intestinal epithelial VDR and clearly define the mechanisms by which intestinal epithelial 
VDR regulates intestinal homeostasis; 2) study a well-controlled system without having to 
feed the mice a special calcium-enriched diet; and 3) avoid other non-digestive disorders 
found in total VDR−/− mice.
Absence of intestinal epithelial VDR leads to ecologic change in bacterial profiles
Interestingly, bacterial abundance is significantly changed in VDRΔIEC mice compared with 
the VDRloxP/loxP mice without any treatment; demonstrating increased E. coli and 
Bacteroides and decreased butyrate-producing bacteria (Butyrivibrio) (figure 1C).Our 454 
16S rRNA sequencing data also shown the altered bacterial profile in the VDRΔIEC mice. 
Principal Coordinate Analysis (PCoA) indicated that fecal microbial communities differ in 
VDRΔIEC mice compared to VDRloxP/loxP (figure1D). The relative abundance of bacteria 
was shifted in VDRΔIEC mice compared to VDRloxP/loxP (figure1E).These data are 
consistent with our 454 16S rRNA sequencing of cecal and proximal colon samples that 
revealed different taxa abundances with a significant increase in the proportion of 
Bacteroides in whole body VDR KO mice relative to WT mice (data not shown). These 
results are also consistent with a study which showed commensal Bacteroides species induce 
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colitis.82 Bacteroides fragilis, a common human commensal microbiota, has been associated 
with IBD.83-85 To examine the distribution and abundance of bacteria, we performed FISH 
fluorescence in situ hybridization (FISH) staining for Bacteroides fragilis. Our data show 
enhanced Bacteroides fragilis in the VDRΔIEC mice compared with the VDRloxP/loxP mice 
(figure 1F).
VDRΔIEC mice are susceptible to chemical injury
To investigate the biological effects of intestinal epithelial VDR in response to injury, we 
used a dextran sulfate sodium (DSS)-colitis model.86 Our data showed that VDRΔIEC mice 
were susceptible to DSS-mediated inflammation than VDRloxP/loxP mice (figure2). The 
VDRΔIEC mice had significant loss of body weight after DSS treatment for 7 days (figure 
2A). The cecum length was significantly reduced in the VDRΔIEC mice with DSS compared 
to VDRΔIEC mice without DSS, whereas no significant change was found between 
VDRloxP/loxP mice with or without DSS (figure 2B). In VDRΔIEC mice with DSS, fecal 
blood was more obvious, stools were less formed, and more weight was lost. Accordingly, 
the Disease Activity Index was significantly increased compared to the VDRloxP/loxP group 
(P< 0.05). (figure. 2C) The H&E staining data in figure. 2D showed more severe intestinal 
inflammation in VDRΔIEC mice with DSS compared with the VDRloxP/loxP mice. Next, the 
level of intestinal inflammation was quantified histologically in a blinded fashion by a 
trained pathologist. The inflammation score in the DSS-treated VDRΔIEC mice was 
significantly higher than the DSS-treated VDRloxP/loxP mice (figure 2E). Since, the 
microbiota may play a role in the vulnerability of the VDRΔIEC mice to DSS, we examined 
the transmissibility of the phenotype by performing a co-housing experiment and then 
challenging the mice with DSS. We found that the co-housing increased disease activity 
index of VDRloxP-loxP mice to a level similar to that seen with the VDRΔIEC mice (figure 2F 
compared to 2C). The co-housing data suggest that the absence of intestinal epithelial VDR 
confers a transmissible risk for DSS-induced colitis. Taken together, our data indicate that 
intestinal VDR contributes to host protection against inflammation.
Absence of Intestinal epithelial VDR leads to abnormal Paneth cells
Paneth cells are specialized intestinal epithelial cells that secrete AMPs,42-44 sense 
commensal bacteria, and maintain homeostasis at the intestinal-microbial interface.48 We 
counted the number of Paneth cells, using a previously reported method to stain 
Lysozyme.59 Abnormal Paneth cells were grouped as D1 (disordered), 2 (depleted), and D3 
(diffuse) (figure 3A). We found fewer than normal Paneth cells in the VDRΔIEC mice ileum 
than in VDRloxP/loxP mice (figure3B). The abnormal Paneth cells D1-D3 increased in the 
VDRΔIEC mice (figure 3C). Abnormal Paneth cells lead to decreased Lysozyme (Lyz1 and 
Lyz2) at the mRNA level (figure 3D).
Intestinal epithelial deletion of VDR down regulates ATG16L1 and autophagy that can 
impair Paneth cell function
Deficits in the autophagy pathway can impair Paneth cell function. Autophagy plays an 
essential role in innate immunity.49 The IBD susceptibility geneATG16L1 is involved in 
autophagy and contributes to inflammation and dysbiosis.87 Our data showed that deletion 
Wu et al. Page 9
Gut. Author manuscript; available in PMC 2015 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
of intestinal epithelial VDR leads to a significant reduction of ATG16L1 protein in vivo 
(figure4A).The protein level of lysozyme, another component of the autophagy pathway, 
was also significantly lower in VDRΔIEC mice (figure4A). We found that mRNA levels of 
ATG16L1 were lower in VDRΔIEC mice compared to the control VDRloxP/loxP mice (figure 
4B). P62 is a signaling adaptor that accumulates in autophagy-deficient mice. 88, 89 We also 
found p62 protein increased in VDRΔIEC mice (figure 4C).
VDR knockout decreases ATG16L1 and LC3B proteins in SKCO15 and MEF cells
The ATG genes control autophagosome formation through ATG12-ATG5 and microtubule-
associated protein1 light chain 3 (LC3-II or ATG8-II) complexes. In a loss of function 
experimental model, we further determined the effects of VDR on autophagy. We knocked 
down VDR protein with siRNA in human colon adenocarcinoma-derived epithelial 
SKCO15 cells. We found that VDR knockdown led to significantly decreased ATG16L1 
and lysozyme at the protein levels (figure 4D).
We used VDR−/− and VDR+/− mouse embryonic fibroblast (MEF) cells to test whether one 
allele of the VDR gene was sufficient to re-establish a normal autophagy phenotype, and 
found that complete lack of VDR led to lower expression levels of ATG16L1, lysozyme, 
and LC3 II (figure 4E). Moreover, in a starvation-induced autophagy model, we found that 
the LC3 II level was significantly lower in VDR−/− MEF incubated in FBS free E-MEM 
medium, compared to VDR+/− after starvation, although LC3 II was increased by starvation 
in both VDR−/− and VDR+/− MEF cells (figure 4F). Using lysotracker Red to mark 
lysosome in vitro,90 we further showed differences in autophagy activity in VDR−/− and 
VDR+/− MEF cells (figure 4G). Without any treatment, the basal level of lysotracker Red 
uptake was already lower in VDR−/− MEF, compared to VDR+/− cells. After starvation for 2 
hours to induce autophagy in cells, lysotracker Red uptake was enhanced. However, there 
was still less autophagy in the cells lacking VDR, compared to the VDR+/− MEF cells 
(figure 4G).
Enhanced VDR protein is associated with elevated autophagy markers within intestinal 
epithelial cells
Based on our observations, we further determined the possibility for restoration of intestinal 
epithelial VDR. We hypothesized that the status of VDR changes the expression of 
autophagy markers. Vitamin D3 is known to increase VDR by blocking ubiquitin/
proteasome-mediated degradation.91 To explore the impact of enhanced VDR on autophagy, 
we investigated the response in the human colonic epithelial cell line INT 407. Vitamin D3 
increased LC3 II/I associated with increased VDR in a time dependent manner. It also 
increased ATG16L1 associated with elevated level of VDR protein (figure 4H). Activated 
VDR is known to bind to the vitamin D-response element (VDRE) in the promoter of target 
genes to regulate gene transcription. We further identified the VDRE in the ATG16L1 gene 
by CHIP assay (figure 4I). Taken together, our data suggested that VDR expression status 
was able to change autophagy marker ATG16L1, LC3 II, and autophagy activity.
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Decreased VDR expression is observed in UC patients and in an experimental colitis 
IL10−/− model
The VDR is associated with chronic inflammation.8, 23 Intestinal VDR expression is 
decreased in patients with UC as shown in figure 5A, which is consistent with the 
literature.8, 23 Moreover, in the inflamed human intestine with low VDR, increased 
Bacteroides was identified by FISH. Intestinal ATG16L1 staining is also very weak in 
patients with UC (figure 5C). We found a similar trend of VDR and ATG16L1 expression in 
an experimental colitis model, where IL10−/− mice spontaneously develop IBD.92 A 
significant decline in the expression of VDR was found in IL10−/− mice with colitis 
symptoms compared to mice without colitis symptoms (figure 5D). Moreover, we also 
found decreased ATG16L1 in intestinal epithelial cells in experimental colitis model (figure 
5D).
Bacterial product butyrate upregulates VDR in human epithelial cells in vitro
Our microbiome data (figure1C) indicate that butyrate-producing bacteria (Butyrivibrio) was 
decreased in the in VDRΔIEC mice. Moreover, a recent study indicate that dysbiosis in 
intestine leads to less butyrate-producing bacteria or less butyrate in intestine.93 We 
pretreated human intestinal epithelial cells with butyrate and found that it significantly 
increased VDR expression at the mRNA and protein levels (figure 6A and 6B). In the 
human intestinal epithelial cell line HCT116, VDR protein and mRNA were increased by 
butyrate in a dose–dependent manner (figure 6C and D). We further investigated VDR 
transcriptional activity following stimulation with butyrate in the human intestinal epithelial 
cell line HCT116. In cells transfected with the VDR reporter plasmid, butyrate significantly 
induced VDR transcriptional activity compared to control cells without butyrate stimulation. 
The relative fold increase was compared with cells transfected with the negative control 
plasmid (Negative) (figure 6E). Additionally, the expression of VDR target genes Cyp27 
and cathelicidin increased significantly after butyrate treatment in the human epithelial cells 
(figure 6F).
Butyrate treatment increases VDR and suppresses inflammatory cytokine IL-6 in a IL10−/− 
colitis model
We further used the experimental colitis IL10−/− model to investigate the in vivo 
physiological relevance of VDR regulation of epithelial function, including responses to 
bacterial products and anti-inflammatory effects. Butyrate treatment significantly increased 
VDR at the mRNA and protein levels in the IL10 knockout mice (figure 7A&B). After 
butyrate treatment, intestinal ATG16L1 was also significantly increased at the mRNA level 
(figure 7C) and suppression of inflammatory cytokine IL-6 was also observed in the IL10 
knockout mice (figure 7D). Meanwhile, butyrate treatment increased the normal Paneth cells 
ratio (figure 7E). These data suggest that enhancing VDR expression by a bacterial product 
is able to stimulate autophagy marker ATG16L1, restore number of Paneth cells, and 
suppress inflammation in colitis.
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Discussion
The positive association of vitamin D deficiency and VDR polymorphisms with IBD 
suggests that vitamin D metabolism and VDR likely plays a vital regulatory role in this 
disease.94, 95 Our study and others indicate that VDR deletions exaggerate colitis through 
activation the NF-κB pathway.25, 26 However the exact role of intestinal VDR in IBD and 
inflammation remains elusive. In the current study, we established a VDRΔIEC mouse 
model, with selective knockout of VDR expression in intestinal epithelial cells, to 
investigate the role of VDR on intestinal inflammation, autophagy, antimicrobial peptide 
expression, and microbiota composition. This study shows that VDR acts as a master 
regulator of intestinal homeostasis and establishes a unifying link between VDR, autophagy, 
the intestinal microbiota, and innate immunity, all factors that have been implicated in the 
pathogenesis of IBD.
Many studies report a link between autophagy and IBD,96, 97 and in a study of the 
intracellular bacterium M. tuberculosis, 1,25-dihydroxyvitamin D3 was shown to induce 
autophagy in human monocytes.61 Our previously published work with Salmonella 
typhimurium, another intracellular pathogen, indicated that VDR-null mutant mice have 
worse outcomes with Salmonella-induced infection than wild-type controls.65 Since 
autophagy is important in host defense and to help limit systemic dissemination of 
Salmonella, we sought to investigate the specific impact of an intestinal VDR deletion on 
autophagy. Significantly lower amounts of ATG16L1 were found in VDRΔIEC compared to 
the VDRloxP/loxP controls at both the protein and transcriptional levels, while leaving the 
other regulators of autophagy intact (e.g., mTOR, phospho-p70 S6 kinase, Beclin-1, data not 
shown). ATG16L1 is one of the “core ATG proteins’’, required to form the ATG5-ATG12-
ATG16L1 complex to promote elongation and closure of the autophagosome.98 Lack of 
ATG16L1 led to autophagy deficiency in mouse cells.58, 59 Lysozyme, one of the proteases 
in lysosomes, is associated with autophagy maturation.99, 100 Our data showed VDR 
knockout decreased lysozyme in VDR−/− MEF cells and ileal epithelial cells. This data 
further indicated that loss of VDR protein may result in a defect of autophagy maturation in 
cells. Others have similarly reported lack of lysozyme staining in the mucus of ATG16L1 
mutant mice.13
Lysozyme is also a component and marker of the Paneth cell secretory granule. Paneth cells 
are specialized epithelial cells primarily located in the small intestine. Paneth cells secrete 
granules containing antimicrobial peptides including lysozyme.101,102, 103 Our data showed 
that the total amount and normal expression pattern of Paneth cell decreased in VDR−/− 
mouse ileum. Defective lysozyme and Paneth cell in VDRΔIEC intestine indicates an 
abnormality of Paneth cell secretion, particularly in the granule exocytosis pathway. VDR−/− 
ileum contained an increased proportion of Paneth cells with disorganized or diminished 
granules or exhibiting diffuse cytoplasmic lysozyme staining. The total amount of Paneth 
cells also decreased in VDR−/− mice. Interestingly, an ATG16L1 mutation was shown to 
confer Paneth cell defects in Norovirus-infected mice as well as Crohn’s disease patients.59 
Hence, loss of normal ATG16L1 gene function may result in aberrant Paneth cell function, 
suggesting that Paneth cell dysfunction may play an important role in IBD.59 Another gene 
linked to IBD, XBP1 has also been implicated in severe Paneth cell and goblet cell 
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dysfunction.104 These studies are consistent with our findings of aberrant Paneth cell 
function, suggesting that the loss of the ability to secrete antimicrobial peptides may be an 
important factor in the development of intestinal inflammation and IBD.
The intestinal Paneth cells are known to secrete anti-microbial peptides and shape the 
composition of the microbiome.87, 88 Paneth cells play a key role in establishing and 
maintaining the intestinal microbiota, and the ability of Paneth cell alpha defensins to 
remodel the gut microbiota communities has been well described.105 VDRΔIEC mice were 
found to have increased bacterial loads and a shift of species (increased E. coli and 
Bacteroides and decreased butyrate-producing bacteria) and developed a more severe DSS-
induced colitis, compared to the VDRloxP/loxP mice, suggesting that microbial dysbiosis in 
VDRΔIEC mice may sensitize the colonic mucosa to chemical injury induced by DSS. It is 
possible that a defect in this first line mucosal clearance of microbes may ultimately 
contribute to excessive chronic inflammatory responses. In the IL10−/− experimental colitis 
model, we were able to increase intestinal VDR expression by administration of the bacterial 
metabolite, butyrate, and decrease IL-6 inflammatory cytokine expression, consistent with 
what has been described by others.106
Our data showed dysbiosis, including decreased abundance of Butyrivibrio, in VDRΔIEC 
mice increase risk for colitis. Dysbiotic microbial ecology is known to contribute to the 
pathogenesis of IBD and could be corrected by fecal transplantation, based on a recent study 
using Nod2-deficient mice69. Our co-housing data indicate that the absence of intestinal 
epithelial VDR confers a transmissible risk for DSS-induced colitis. Therefore, for the 
VDR-deficient mice, there are several potential strategies to correct colitis by: 1. treating 
mice with butyrate, a bacterial natural product; 2. enhancing intestinal VDR expression; and 
3. fecal transplantation. We will explore fecal transplantation in a future study.
In skin, cathelicidin is a direct target of VDR and is upregulated by vitamin D.107 Vitamin D 
is thought to be an important regulator for antimicrobial peptides found in skin, but our 
study indicates that VDR may be similarly important for AMP expression in the intestine. 
The regulatory networks that control AMP expression still need to be fully defined, but our 
findings may have important implications not only for understanding the mechanisms of 
vitamin D and microbiota remodeling in the gut, but also for other epithelial cell-based 
autoimmune diseases such as psoriasis 108 where dysbiotic microbial communities and 
aberrant immune responses may similarly play a role in pathogenesis.
In conclusion, our data indicate that intestinal VDR plays a fundamental role in intestinal 
homeostasis through its effects on autophagy, on Paneth cells, and on the intestinal 
microbiota itself. There are mutual interactions between vitamin D, VDR and the 
microbiome that still remain to be fully understood. However, our study suggests that 
intestinal VDR may represent a master regulator of inflammation, by regulating autophagy 
and the production of antimicrobial peptides that, in turn, are responsible for remodeling the 
bacterial communities that comprise the intestinal microbiota. All of these factors 
(inflammation, autophagy, microbiota composition) have been implicated in the 
pathogenesis of IBD; we propose that all of these factors may in fact be regulated under the 
control of one master regulatory pathway, through VDR (figure 7F). Although the complex 
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regulatory network that controls each of these aspects still needs to be fully elucidated, our 
findings are important not only for a better understanding IBD but may also have 
applicability for other autoimmune diseases (such as those of the skin, lung), where the host 
is in contact with bacteria, and aberrant immune responses and microbiota dysbiosis are 
implicated. Insights gained from understanding how the VDR pathway is integrally involved 
in regulating autophagy and changing microbiome diversity may serve as a paradigm for 
understanding the nature of host defense signals in inflammation.
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Significance of this study
What is already known on this subject?
Vitamin D and the vitamin D receptor (VDR) appear to be important immunological 
regulators of inflammatory bowel diseases (IBD). Low vitamin D status has been 
observed in IBD patients. A north-south gradient in rates of Crohn’s disease (CD) 
suggests that vitamin D deficiency may be an environmental trigger contributing to the 
pathogenesis of IBD. Moreover, polymorphisms in the VDR gene are associated with 
susceptibility to IBD. VDR expression is significantly decreased in IBD patients. 
Bacteria regulate intestinal VDR expression in both gnotobiotic and bacterial-colitis 
models. Under conditions of intestinal inflammation, VDR negatively regulates bacteria-
induced proinflammatory NF-κB activity.
What are the new findings?
Our study for the first time links dysbiosis, innate immune functions (Paneth cells), and 
genetic susceptibility through intestinal epithelial VDR. Our data provide insights by 
specifically investigating how intestinal epithelial VDR regulates autophagy and Paneth 
cells through the autophagy gene ATG16L1, thus changing the microbiome profile. We 
further show that low levels of VDR correlate with decreased ATG16L1 in the intestine 
of IBD patients and in an experimental colitis model. Gain- and loss-of- function assays 
show that VDR transcriptionally regulates ATG16L1, thus decreasing lysozyme. Finally, 
administration of the bacterial product butyrate increases intestinal VDR and ATG16L1 
expression and suppresses inflammation in an experimental colitis model. Our study fills 
an existing gap by characterizing the precise role of intestinal epithelial VDR in 
regulating intestinal homeostasis through alterations in intestinal autophagy and the 
microbiome. It also brings up the possibility that microbial natural products can be use 
therapeutically to restoration VDR-dependent functions in patients with IBD.
How might it impact on clinical practice in the foreseeable future?
Our studies demonstrate a fundamental relationship between vitamin D, VDR, Paneth 
cell function, gut microbiota, and genetic susceptibility genes (ATG16L1) that is 
essential for the maintenance of intestinal homeostasis, but also for the development of 
chronic states of mucosal inflammation. This knowledge can be immediately used to 
develop intestinal VDR as a clinical biomarker for identifying patients who might benefit 
from currently available interventions, as well as for the eventual development of novel 
strategies for the prevention and treatment of human IBD.
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Figure 1. 
Established intestinal epithelial cell VDR KO (VDRΔIEC) mice and their bacterial profile. 
(A) VDR immunohistochemistry staining in intestine. (B) Western blotting of intestinal 
VDR. Villin is a marker for IECs. (C) Real-time PCR of bacterial universal 16srDNA and 
16s rDNA for E.coli, Bacteroides fragilis and, Butyrivibrio fibrisolvens. Primers specific to 
18S rRNA were used as an endogenous control to normalize loading between samples. The 
relative amount of 16S rRNA in each sample was estimated using the ΔΔCT method. (n=3,* 
P<0.05) (D) Principal Coordinates Analysis (PCoA) of unweighted UniFrac distances of 16 
S rRNA genes. Analysis for VDRloxP/loxP (blue) and VDRΔIEC (red) mice. The results 
indicate that fecal microbial communities differ in VDRΔIEC mice compared to 
VDRloxP/loxP. (E) Bacterial community of fecal samples from VDRΔIEC and VDRloxP/loxP 
mice, using 454 16S rRNA sequencing data.(n=4/group) (F) Representative fluorescence in 
situ hybridization staining for Bacteroides fragilis (red) in VDRΔIEC and VDRloxP/loxP 
control mice. Blue, DAPI.
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Figure 2. 
VDRΔIEC mice have worse outcomes with DSS-induced colitis. (A) Relative body weight 
changes in mice with or without DSS. (B). Cecum shorten was found in VDRΔIEC mice with 
colitis. (C)Disease Activity Index of colon from mice with or without DSS treatment. (D) 
Representative H&E histology of colon from mice with or without DSS treatment. (E) 
Inflammatory scores of the mouse intestine with or without DSS. VDRloxP/loxP and 
VDRΔIEC mice were administrated with DSS. n=5/group, * P<0.05. (F) Inflammatory scores 
of intestine after co-housing VDRloxP/loxP and VDRΔIEC mice. Two to three month old 
female VDRloxP/loxP and VDRΔIEC were co-housed in new cages at 3:2 or 2:2 mice. After 4 
weeks of co-housing, the mice were administered with 5% DSS for 7 days to induce colitis. 
The dysbiosis associated with VDR deficient mice appears to confer risk of chemically 
induced colitis. VDRloxP/loxP mice co-housed with VDRΔIEC mice developed the similar 
inflammation as the VDRΔIEC mice.
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Figure 3. 
VDR affects patterns of Paneth cells in VDRΔIEC mice. (A) Representative images showed 
patterns of Paneth cells. D0, normal (yellow circle); D1, disordered (green circle); D2, 
depleted (yellow circle); D3, diffuse (yellow circle). (B) Representative images of indirect 
immunofluorescence of sections stained for lysozyme (red) in ileal crypts of VDRΔIEC and 
VDRloxP/loxP mice. (C) Percentage of Paneth cells displayed normal and abnormal (D1 to 
D3) patterns of lysozyme expression (n=10/group, * P<0.05). (D) Decreased lysozyme (lyz) 
in VDRΔIEC mice (n=3/group, * P<0.05).
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Figure 4. 
VDR regulation of the expression levels of autophagy related genes. (A) Levels of 
ATG16L1 protein and lysozyme in VDRΔIEC and VDRloxP/loxP mice. The relative intensity 
of ATG16L1 and lysozyme. (n=3/group. *P<0.05). (B) ATG16L1 mRNA level decreased in 
VDRΔIEC (n=3, *P<0.05 ). (C) Levels of P62 protein in VDRΔIEC and VDRloxP/loxP mice. 
The relative intensity of P62. (n=3 /group. *P<0.05). (D) ATG16L1 and lysozyme were 
decreased in intestinal epithelial cells with knockdown VDR by SiRNA VDR. (E) Lacking 
of VDR induced the reductions of autophagy marks (ATG16L1 and lysozyme) in MEF 
cells. (F) Expression of LC3 II in VDR−/− and VDR+/− MEF cells. MEF cells were cultured 
to 80% confluence. Incubated in FBS free E-MEM for 2 hours as starvation (st). Cell lysates 
were immunoblotted with antibodies against LC3B and beta-actin. (G)Representative 
images of lysotracker staining in MEF VDR−/− and VDR+/− cells. MEF cells were grown in 
the Lab-Tek Chambered coverglass System, incubated in FBS free E-MEM for 2 hours as 
starvation, and incubated with 100 nM LysoTracker red lysosomal probe for 60 min. After 
washing with HBBS, the cells were detected under fluorescence microscopy (AMG, EVOS 
fl).(H) ATG16L1 was increased with the other autophagy markers (LC3, ATG16l1) in 
intestinal INT407 cells with enhanced VDR by vitamin D treatment. (I) Regions 
encompassing putative VDRE amplified by PCR in ChIP assays in vitro.
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Figure 5. 
VDR expression in human intestine and colitis models. (A) Intestinal VDR staining is very 
weak in inflamed colon of Ulcerative colitis (UC) patients. (B) Representative FISH staining 
for Bacteroides fragilis (red) in tissues from UC patients. Blue, DAPI. Normal, normal 
tissue adjacent lesion area; Ulcerative colitis, lesion area. (C) Representative Intestinal 
ATG16L1 staining is very weak in inflamed colon of IBD patients. (D) Decreased VDR and 
ATG16L1 in the IL10−/− mice with colitis symptom. Data are presented as the mean ± SD 
from 5 mice/group.
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Figure 6. 
Bacterial product butyrate activates VDR signaling pathway in human intestinal epithelial 
cells. (A) Butyrate increased VDR protein level in MEF cells. (B) Butyrate increased VDR 
and lysozyme mRNA levels. (C) Butyrate increased VDR protein level in dose-dependent 
manner in HCT116 cells. (D) Butyrate increased VDR mRNA level in dose-dependent 
manner in HCT116 cells. (E) Butyrate increased the VDR transcription activity in human 
epithelial cells. HCT116 cells were transfected with Cignal Vitamin D Reporter (luc) Kit. 
After transfection for 24 hours, cells were treated with 10 mM butyrate for 30h, and 
luciferase activity was determined. Firefly luciferase activity was normalized to Renilla 
luciferase activity, and the activity was expressed as relative luminescence units. (F) 
Butyrate increased cyp24 and cathelicidin mRNA levels in dose-dependent manner.
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Figure 7. 
Butyrate treatment restores VDR expression in colitis and inhibits inflammation. (A) 
Butyrate increased VDR protein in IL10−/− mice. IL10−/− mice were given 2% sodium 
butyrate in the drinking water for 3 weeks. (B) Butyrate increased VDR mRNA level in 
IL10−/− mice colon. (C) Butyrate increased ATG16L1 mRNA levels in IL10−/− mice. (D) 
Butyrate decreased IL6 mRNA level. (n=4, * P<0.05).(E) Representative images of indirect 
immunofluorescence of sections stained for lysozyme (red) in ileal crypts of IL10−/− mice 
with/without butyrate treatment. Percentage of Paneth cells displayed normal and abnormal 
(D1 to D3) patterns of lysozyme expression (n=4/group, * P<0.05). (F) A working model of 
VDR in intestinal and microbiome homeostasis.
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Table 1
Real time PCR primers
Gene name Primers
mouse lyz1 F GAGACCGAAGCACCGACTATG
mouse lyz1 R CGGTTTTGACATTGTGTTCGC
mouse lyz2 F ATGGAATGGCTGGCTACTATGG
mouse lyz2 R ACCAGTATCGGCTATTGATCTGA
mouse DEFars1 F AGCAGCCATTGTGCGAAGAA
mouse DEFars1 R TGCTGTGTATTTGGAGCTTGG
mouse DEFa5 F AGGCTGATCCTATCCACAAAACAG
mouse DEFa5 R TGAAGAGCAGACCCTTCTTGGC
Mouse DEFa22-F ACCAGGCTGTGTCTGTCTCCTT
Mouse DEFa22-R TGGCCTCAGAGCTGATGGTTGT
Mouse RIP3g-F GGTGAGGAGCATTAGTAACAGC
Mouse RIP3g-R CCAGGGTTTAAGATGGTGGAGG
Mouse VDR-F GAATGTGCCTCGGATCTGTGG
Mouse VDR-R ATGCGGCAATCTCCATTGAAG
Mouse β-actin-F TGTTACCAACTGGGACGACA
Mouse β-actin-R CTGGGTCATCTTTTCACGGT
Gut. Author manuscript; available in PMC 2015 July 01.
